Silk Road Medical, Inc.
(NASDAQ GS: SILK)
Rigrodsky Law, P.A. is investigating Silk Road Medical, Inc. (“Silk Road”) regarding possible breaches of fiduciary duties and other violations of law related to Silk Road’s agreement to be acquired by Boston Scientific Corporation. Under the terms of the agreement, Silk Road shareholders will receive $27.50 per share in cash.